The global healthcare analytical testing services market size accounted for USD 15,750 million in 2024 and is expected to exceed around USD 35,610 million by 2034, growing at a CAGR of 8.5% from 2024 to 2034.
The healthcare analytical testing services market refers to the production, distribution, and use of these services, which include chromatography, spectroscopy, trace analysis, simulated distillations, contamination identification, troubleshooting, routine quality control, and submitted sample analysis. Analytical testing is a cornerstone of pharmaceutical quality and safety. These services play an important role in biomarker, pharmacokinetic, and bioanalytical testing. There is a high demand for these services in forensic labs, clinics, hospitals, nutraceuticals & cosmetic companies, biopharmaceutical companies, medical device companies, and pharmaceutical companies, which is driving the growth of the healthcare analytical testing services market.
However, the risk factors of the market include sample integrity & quality control issues, shortages of skilled workforce, cost pressures, lack of advanced technologies, and supply chain disruptions that can slow down the growth of the market. The future scope of the market includes telehealth and remote testing solutions, a focus on patient-centric services, strategic partnerships and collaborations, expanding services, and integration of machine learning (ML) and artificial intelligence (AI) can improve data analysis, which will help the growth of the healthcare analytical testing services market.
Published by Ajit Bansod
